The Strategic Action Plan, conducted by PLANET, for the development of the Greek Pharmaceutical Industry was presented at a dedicated conference,  jointly organized by the Hellenic Ministry of Economy, Development and Tourism, the Hellenic Ministry of Health and the Hellenic Ministry of Education, Research and Religious Affairs, under the auspices of Deputy Prime Minister on the 15th of September at Michael Cacoyannis Foundation.

The aim of the event was to bring together all key sector stakeholders, in order to invite them to discuss the current state of the Greek Pharmaceutical Industry and its potential and to present them the necessary actions in order to realize them. The conference was welcomed by the Deputy Prime Minister Giannis Dragasakis, Minister of Health Andreas Xanthos, Acting Minister of Education, Research and Religious Affairs Kostas Fotakis (Research and Innovation sector) and the President of SEV Theodoros Fessas (Hellenic Federation of Enterprises).

Mrs. Machy Karagianni, COO of PLANET presented the main pillars of the Action Plan. Key representatives of the sector also gave speeches, among which the Deputy Minister of Economy, Development and Tourism (Industry sector), the President of the Panhellenic Union of Pharmaceutical Industry, the President of the National Organization for Medicines and the President of the Panhellenic Union of Pharmaceutical Industry.

All participants acknowledged the importance of such a Strategic Action Plan, as well as the need of seamless coordination and collaboration among related stakeholders from the public and private sector, in order to successfully implement the proposed Action Plan.

The Action Plan, highlights the existing barriers the Greek Pharmaceutical Industry faces, as well as its prospects, drawing special attention to the need to strengthen the sector’s position in the internal market and enhance its export profile. Complementary measures to strengthen the research and innovation sector, with a shift to new products have also been proposed. Additionally, measures for strengthening the sector’s human capital, supporting structures and infrastructures along with funding instruments are foreseen in the Study.

The six pillars of the Action Plan for the development of the domestic Pharmaceutical Industry are:

1. Reinforcement of Demand for Domestic Pharmaceutical Industry Products
2. Reinforcement of competitiveness of the domestic pharmaceutical industry
3. Reinforcement of research and innovation activities
4. Human Capital Enhancement
5. Ensurance of  supporting services and infrastructure
6. Improvement of financing environment
   

   ---